GMO TECH Balance Sheet Health

Financial Health criteria checks 5/6

GMO TECH has a total shareholder equity of ¥1.0B and total debt of ¥227.0M, which brings its debt-to-equity ratio to 21.8%. Its total assets and total liabilities are ¥2.4B and ¥1.4B respectively. GMO TECH's EBIT is ¥762.0M making its interest coverage ratio 381. It has cash and short-term investments of ¥1.2B.

Key information

21.8%

Debt to equity ratio

JP¥227.00m

Debt

Interest coverage ratio381x
CashJP¥1.17b
EquityJP¥1.04b
Total liabilitiesJP¥1.36b
Total assetsJP¥2.40b

Recent financial health updates

Recent updates

Optimistic Investors Push GMO TECH, Inc. (TSE:6026) Shares Up 30% But Growth Is Lacking

Dec 11
Optimistic Investors Push GMO TECH, Inc. (TSE:6026) Shares Up 30% But Growth Is Lacking

GMO TECH (TSE:6026) Could Easily Take On More Debt

Nov 07
GMO TECH (TSE:6026) Could Easily Take On More Debt

Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

Sep 13
Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 10
GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Is GMO TECH (TSE:6026) A Risky Investment?

Aug 02
Is GMO TECH (TSE:6026) A Risky Investment?

GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Feb 27
GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Financial Position Analysis

Short Term Liabilities: 6026's short term assets (¥2.1B) exceed its short term liabilities (¥1.2B).

Long Term Liabilities: 6026's short term assets (¥2.1B) exceed its long term liabilities (¥170.0M).


Debt to Equity History and Analysis

Debt Level: 6026 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if 6026's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 6026's debt is well covered by operating cash flow (141.9%).

Interest Coverage: 6026's interest payments on its debt are well covered by EBIT (381x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:41
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GMO TECH, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Taro IshiharaDaiwa Securities Co. Ltd.
Kaname FujitaIchiyoshi Research Institute Inc.